PMC:7306567 / 36468-36644
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T185 | 48-51 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
| T186 | 110-113 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T231 | 14-17 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T232 | 65-68 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T266 | 0-176 | Sentence | denotes | P Wei-Lun Liu has received research grants from MSD, Pfizer, and has served as an invited speaker for Gilead, MSD, Pfizer, Astellas Pharma, and is an advisor to Pfizer, Gilead. |